Literature DB >> 20512450

Impact of systemic sclerosis on electromechanical characteristics of the heart.

Tansu Karaahmet1, Kursat Tigen, Emre Gurel, Mumtaz Takir, Anil Avci, Cihan Cevik, Selcuk Pala, Cihan Dundar, Yelda Basaran.   

Abstract

Primary myocardial involvement is common in systemic sclerosis (SSc). We evaluated the atrial and ventricular electromechanical characteristics by using tissue Doppler echocardiography in SSc patients with subclinical cardiac involvement. Twenty-seven consecutive patients (24 women; mean age +/- SD 49.9 +/- 11.3 years) presenting with SSc without pulmonary arterial hypertension or symptomatic heart failure were prospectively studied. Electrocardiographic P-wave dispersion (Pd), corrected QT dispersion (QTcd), interatrial, intra-atrial, interventricular, and intraventricular electromechanical delays were analyzed by tissue Doppler echocardiography, and brain natriuretic peptide levels were measured. Results were compared with 17 healthy controls. There was no difference in conventional and tissue Doppler parameters between the two groups. However, patients with SSc had higher mean Pd (mean [+/-SD] 46.8 +/- 15 and 36 +/- 8 ms, respectively, P = 0.004) and mean interatrial electromechanical delay time (DT) (mean [+/-SD] 32.2 +/- 9.2 and 24.7 +/- 9.7 ms, respectively, P = 0.01), mean electromechanical delay time for all segments (Mean Ts) (mean [+/-SD] 148.8 +/- 18.8 and 129.3 +/- 13.4 ms, respectively, P < 0.001), and intraventricular DT (mean [+/-SD] 27.6 +/- 12.5 and 16.2 +/- 7.2 ms, respectively, P < 0.001). Intraventricular DT was the only parameter that correlated significantly with the Mean Ts. Brain natriuretic peptide levels were within normal limits in both groups; however, they were higher in patients with SSc than in controls (mean [+/-SD] 37.5 +/- 28.5 and 23.1 +/- 16.0 pg/ml, respectively, P = 0.03). The evaluation of atrial and ventricular electromechanical parameters by using tissue Doppler echocardiography seems to be useful for detection of subclinical cardiac involvement in SSc patients with normal conventional echocardiographic findings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512450     DOI: 10.1007/s00380-009-1197-3

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  25 in total

1.  Myocardial contractility is early affected in systemic sclerosis: a tissue Doppler echocardiography study.

Authors:  Christophe Meune; Yannick Allanore; Olivier Pascal; Jean-Yves Devaux; Odile Dessault; Denis Duboc; Simon Weber; André Kahan
Journal:  Eur J Echocardiogr       Date:  2005-02-25

2.  Cardiac score. A semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis.

Authors:  P J Clements; P A Lachenbruch; D E Furst; H E Paulus; M G Sterz
Journal:  Arthritis Rheum       Date:  1991-11

3.  De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease.

Authors:  T N James
Journal:  Circulation       Date:  1974-10       Impact factor: 29.690

4.  Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.

Authors:  B H Bulkley; R L Ridolfi; W R Salyer; G M Hutchins
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

5.  Autonomic dysfunction and microvascular damage in systemic sclerosis.

Authors:  Manuela Di Franco; Michele Paradiso; Valeria Riccieri; Stefania Basili; Antonio Mammarella; Guido Valesini
Journal:  Clin Rheumatol       Date:  2007-01-18       Impact factor: 2.980

6.  A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma).

Authors:  W P Follansbee; T R Miller; E I Curtiss; J E Orie; R L Bernstein; J M Kiernan; T A Medsger
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

7.  The cardiac conduction system in progressive systemic sclerosis. Clinical and pathologic features of 35 patients.

Authors:  R L Ridolfi; B H Bulkley; G M Hutchins
Journal:  Am J Med       Date:  1976-09       Impact factor: 4.965

8.  Ventricular late potentials in systemic sclerosis: relationship with skin involvement.

Authors:  Michele Paradiso; Manuela Di Franco; Antonino Musca; Stefania Basili; Valeria Riccieri; Vincenzo Paoletti; Antonio De Matteis; Antonio Mammarella
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

9.  Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients.

Authors:  Christophe Meune; Jérôme Avouac; Karim Wahbi; Laure Cabanes; Julien Wipff; Luc Mouthon; Loïc Guillevin; André Kahan; Yannick Allanore
Journal:  Arthritis Rheum       Date:  2008-06

Review 10.  Scleroderma--clinical and pathological advances.

Authors:  Christopher P Denton; Carol M Black
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-06       Impact factor: 4.098

View more
  4 in total

1.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  QT variability index in patients with systemic sclerosis.

Authors:  Udi Nussinovitch; Shiri Rubin; Yair Levy; Merav Lidar; Avi Livneh
Journal:  Eur J Rheumatol       Date:  2018-10-01

3.  Evaluation of left atrial volume and function in systemic sclerosis patients using speckle tracking and real-time three-dimensional echocardiography.

Authors:  Halil Ataş; Alper Kepez; Kürşat Tigen; Fuad Samadov; Gülsen Özen; Altuğ Cincin; Murat Sünbül; Mehmet Bozbay; Haner Direşkeneli; Yelda Başaran
Journal:  Anatol J Cardiol       Date:  2015-07-03       Impact factor: 1.596

4.  Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.

Authors:  Veronika Sebestyén; Gabriella Szűcs; Dénes Páll; Dóra Ujvárosy; Tamás Ötvös; Imre Csige; Tamás Pataki; István Lőrincz; Zoltán Szabó
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.